Accessibility Menu

Neogen(FRA) NG2

Market Cap€2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
€9.92
-0.04%
-0.00Today

Neogen Financials at a Glance

Market Cap

€2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€746.30

Net Income (TTM)

-€6.54

EPS (TTM)

-€0.03

P/E Ratio

-331.91

Dividend

€0.00

Beta (Volatility)

0.08 (Low)

Price

€9.92

Volume

0

Open

€9.92

Previous Close

€9.92

Daily Range

€9.92 - €9.92

52-Week Range

€4.40 - €10.97

Estimated Earnings Date

N/A

NG2 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Neogen

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Industry

Healthcare Equipment and Supplies

Employees

2,636

CEO

Mikhael Nassif

NG2 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-36.15%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-0.30%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

218.06M

Volume

0

Avg. Volume

89.864

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Neogen Performance Analysis

Neogen annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-05-31EUR 788,210,36970.3%
20242024-05-31EUR 854,311,6378.4%
20252025-05-31EUR 827,332,057-3.2%
20262026-05-31EUR 746,306,704-9.8%
Neogen annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-05-31EUR -0.12N/A
20242024-05-31EUR -0.04-65.3%
20252025-05-31EUR -4.6611482.1%
20262026-05-31EUR -0.03-99.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€193.48

+1.0%

Gross Profit

€72.74

+1.2%

Gross Margin

37.59%

+1.2%

Market Cap

€2.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.65

N/A

Employees

2,636

N/A

Net Income

-€9.70

+0.0%

EBITDA

€28.00

+1.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€854.79

-6.8%

Total Debt

€695.83

+0.9%

Accounts Receivable

€125.80

+0.9%

Inventory

€123.66

+0.7%

Long Term Debt

€691.80

+0.9%

Short Term Debt

€4.03

+0.2%

Return on Assets

-21.87%

+0.0%

Return on Invested Capital

-5.39%

-1.3%

Free Cash Flow

€22.54

+17.0%

Operating Cash Flow

€26.35

+2.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About NG2

What is the current price of Neogen?

Neogen is trading at €9.92 per share.

What is the 52-week range for Neogen?

Over the past 52 weeks, Neogen has traded between €4.40 and €10.97.

How much debt does Neogen have?

As of the most recent reporting period, Neogen reported total debt of €695.83M.

How much cash does Neogen have on hand?

Neogen reported €158.96M in cash and cash equivalents in its most recent financial results.

What is Neogen’s dividend yield?

Neogen does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.